| Active Not Recruiting | Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. NCT05318274 | Coordinación de Investigación en Salud, Mexico | N/A |
| Withdrawn | Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Can NCT03091842 | University of Southern California | N/A |
| Withdrawn | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer NCT03238703 | Fred Hutchinson Cancer Center | Phase 4 |
| Completed | Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer NCT03345420 | University of Utah | Phase 2 |
| Active Not Recruiting | Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing NCT02927912 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Terminated | Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors NCT03284346 | University of Southern California | N/A |
| Terminated | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage NCT03128619 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer NCT03139435 | Wake Forest University Health Sciences | N/A |
| Unknown | Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breas NCT03025139 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hor NCT02760030 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) NCT02728596 | SWOG Cancer Research Network | N/A |
| Completed | MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Brea NCT02702830 | Wake Forest University Health Sciences | — |
| Completed | Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-I NCT03050463 | Stanford University | — |
| Completed | Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin NCT02677389 | University of Wisconsin, Madison | N/A |
| Completed | Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors NCT02662335 | Fred Hutchinson Cancer Center | N/A |
| Completed | Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Horm NCT02186470 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | eHealth Weight Loss Program in African American Breast Cancer Survivors NCT02699983 | Rutgers, The State University of New Jersey | N/A |
| Completed | Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer NCT02432950 | City of Hope Medical Center | N/A |
| Completed | Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity NCT02566408 | Case Comprehensive Cancer Center | N/A |
| Completed | Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy NCT02314156 | Northwestern University | Phase 2 |
| Terminated | High-Intensity Interval Training for Stage I-III Breast Cancer Patients NCT02454777 | University of Southern California | N/A |
| Completed | Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering NCT03061175 | Rutgers, The State University of New Jersey | N/A |
| Completed | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Completed | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Earl NCT02526498 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III NCT02203552 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors NCT03039140 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Canc NCT02400060 | Ohio State University Comprehensive Cancer Center | N/A |
| Withdrawn | KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Ca NCT02168179 | Wake Forest University Health Sciences | N/A |
| Completed | Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors NCT02235051 | City of Hope Medical Center | N/A |
| Completed | MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer NCT01805076 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Rad NCT02023008 | Wake Forest University Health Sciences | N/A |
| Completed | Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Ch NCT02002533 | Gary Morrow | N/A |
| Completed | Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer NCT02415387 | Ohio State University Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cance NCT01941784 | Wake Forest University Health Sciences | N/A |
| Terminated | PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer NCT01712815 | University of Southern California | N/A |
| Completed | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer NCT01869764 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Pro NCT03233555 | Rutgers, The State University of New Jersey | N/A |
| Active Not Recruiting | A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) NCT01824836 | ECOG-ACRIN Cancer Research Group | N/A |
| Unknown | Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer NCT01800422 | Northwestern University | Phase 2 |
| Completed | Broccoli Sprout Extract in Treating Patients With Breast Cancer NCT01753908 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Completed | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors NCT01849250 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy NCT01819233 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Active Not Recruiting | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Brea NCT01750073 | University of Nebraska | Phase 2 |
| Terminated | Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Br NCT02370264 | University of Southern California | N/A |
| Completed | Phase I: At-Home Support for Rural Women Using Group Video Calling NCT01672684 | Stanford University | Phase 1 |
| Terminated | Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid NCT01409811 | City of Hope Medical Center | N/A |
| Withdrawn | Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Ca NCT01791998 | University of Chicago | N/A |
| Active Not Recruiting | Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery NCT01570998 | University of California, San Francisco | N/A |
| Completed | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery NCT01483196 | Wake Forest University Health Sciences | N/A |
| Completed | Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastroz NCT01478477 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Nega NCT01928186 | University of Washington | N/A |
| Unknown | Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients NCT01372579 | Northwestern University | Phase 2 |
| Terminated | MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer NCT01319539 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Diindolylmethane in Treating Patients With Breast Cancer NCT01391689 | University of Arizona | N/A |
| Withdrawn | Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer NCT01729832 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing NCT01982591 | Fox Chase Cancer Center | — |
| Withdrawn | Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By NCT01292083 | University of Southern California | N/A |
| Terminated | Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and NCT01276054 | University of Southern California | Phase 2 |
| Terminated | Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Recei NCT01243541 | Northwestern University | N/A |
| Terminated | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT01233505 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Endoscopic Breast Surgery in Treating Patients With Breast Cancer NCT01222377 | University of Southern California | N/A |
| Completed | Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer NCT01219075 | University of Southern California | N/A |
| Completed | Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Sur NCT01106898 | University of Nebraska | Phase 2 |
| Completed | Window of Opportunity Study Targeting the Inflammatory Milieu NCT01881048 | University of Colorado, Denver | EARLY_Phase 1 |
| Completed | Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients NCT01723943 | University of Washington | N/A |
| Completed | Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting NCT00618657 | University of California, Irvine | Phase 2 |
| Completed | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Ca NCT00513292 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That NCT00450879 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanopart NCT00407888 | University of Washington | Phase 2 |
| Completed | Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI NCT02587663 | University of Southern California | N/A |
| Completed | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating NCT00066690 | ETOP IBCSG Partners Foundation | Phase 3 |
| Completed | Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer T NCT00194779 | University of Washington | Phase 2 |